Organic anion transporters involved in the excretion of bestatin in the kidney

被引:41
作者
Zhu, Yanna [1 ]
Meng, Qiang [1 ,3 ]
Wang, Changyuan [1 ,3 ]
Liu, Qi [1 ,3 ]
Sun, Huijun [1 ,3 ]
Kaku, Taiichi [2 ]
Liu, Kexin [1 ,3 ]
机构
[1] Dalian Med Univ, Coll Pharm, Dept Clin Pharmacol, Dalian 116044, Peoples R China
[2] Japan Bioprod Ind Co Ltd, Shibuya Ku, Tokyo, Japan
[3] Dalian Med Univ, Prov Key Lab Pharmacokinet & Transport, Dalian 116044, Peoples R China
基金
中国国家自然科学基金;
关键词
Bestatin; Dipeptide; Drug interaction; Organic anion transporter; Pharmacokinetics; Renal excretion; DRUG-DRUG INTERACTIONS; RENAL UPTAKE; AMINOPEPTIDASE INHIBITOR; RAT; JBP485; CATION; UBENIMEX; PHARMACOKINETICS; IDENTIFICATION; METHOTREXATE;
D O I
10.1016/j.peptides.2012.01.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bestatin, a dipeptide, a low molecular weight aminopeptidase inhibitor, has been demonstrated to be an immunomodulator with an antitumor activity. However, the transporter-mediated renal excretion of bestatin is not fully understood. The purpose of this study was to elucidate the transporter-mediated renal excretion mechanism for bestatin. The plasma concentration of bestatin was increased markedly and both the accumulative renal excretion and renal clearance of bestatin were decreased significantly after intravenous administration of bestatin in combination with probenecid. p-Aminohippuric acid (PAH), a substrate of organic anion transporter (OAT) 1, benzylpenicillin (PCG), a substrate of OAT3 and JBP485, a substrate of OAT1 and OAT3, reduced the uptake of bestatin in rat kidney slices and in hOAT1- or hOAT3-HEK 293 cells. The accumulation of bestatin in hOAT1-HEK and hOAT3-HEK 293 cells was significantly greater than that in vector-HEK, and the K-m and V-max were 0.679 +/- 0.007 mM and 0.807 +/- 0.006 nmol/mg protein/30 s for OAT1, 0.632 +/- 0.014 mM and 1.303 +/- 0.015 nmol/mg protein/30 s for OAT3 respectively. PAH and JBP485 inhibited significantly the uptake of bestatin in hOAT1-HEK with the K-i values of 92 +/- 9 mu M and 197 +/- 21 mu M; and PCG, JBP485 inhibited significantly the uptake of bestatin in hOAT3-HEK 293 cells with the K-i values of 88 +/- 12 mu M and 160 +/- 16 mu M. Our results are novel in demonstrating for the first time that OAT1 and OAT3 are involved in the renal excretion of bestatin. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:265 / 271
页数:7
相关论文
共 47 条
[1]  
ABE F, 1989, CANCER IMMUNOL IMMUN, V28, P29
[2]   Assessment of drug interactions in hepatobiliary transport using rhodamine 123 in sandwich-cultured rat hepatocytes [J].
Annaert, PP ;
Brouwer, KLR .
DRUG METABOLISM AND DISPOSITION, 2005, 33 (03) :388-394
[3]  
BOURKE RS, 1975, CANCER RES, V35, P110
[4]   Structure of renal organic anion and cation transporters [J].
Burckhardt, G ;
Wolff, NA .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2000, 278 (06) :F853-F866
[5]   Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney [J].
Cha, SH ;
Sekine, T ;
Fukushima, J ;
Kanai, Y ;
Kobayashi, Y ;
Goya, T ;
Endou, H .
MOLECULAR PHARMACOLOGY, 2001, 59 (05) :1277-1286
[6]   Characterization of uremic toxin transport by organic anion transporters in the kidney [J].
Deguchi, T ;
Kusuhara, H ;
Takadate, A ;
Endou, H ;
Otagiri, M ;
Sugiyama, Y .
KIDNEY INTERNATIONAL, 2004, 65 (01) :162-174
[7]   Functional involvement of rat organic anion transporter 3 (rOat3; Slc22a8) in the renal uptake of organic anions [J].
Hasegawa, M ;
Kusuhara, H ;
Sugiyama, D ;
Ito, K ;
Ueda, S ;
Endou, H ;
Sugiyama, Y .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 300 (03) :746-753
[8]  
HORI R, 1993, BIOCHEM PHARMACOL, V45, P1763
[9]   Cellular and molecular aspects of drug transport in the kidney [J].
Inui, K ;
Masuda, S ;
Saito, H .
KIDNEY INTERNATIONAL, 2000, 58 (03) :944-958
[10]  
INUI KI, 1992, J PHARMACOL EXP THER, V260, P482